Authors



Owen A. O'Connor, MD, PhD

Latest:

Sharing Experiences: The Most Valuable Resource in Rare Diseases

Owen A. O’Connor, MD, PhD, Director of Center for Lymphoid Malignancies at Columbia University, emphasizes the importance of sharing experiences among physicians and researchers in the rare diseases like peripheral T-cell lymphomas.




Ellen Kurek

Latest:

Antipsychotic Increase Could Harm Mentally Ill TD Patients

An 18-year cohort study of severely mentally ill Afro-Caribbeans reported conflicting advisory from current tardive dyskinesia standards.




Charles W. Scarantino, MD, PhD

Latest:

Wireless Dosimetry

A new way to ensure your patients receive the proper radiation dose where they need it.



Alan L. Wang, MD

Latest:

Checking in on the Nation's Largest Academic Hospital Medicine Program

Alan L. Wang, MD, and Daniel Owens, MBA, discuss the unique characteristics of academic hospital medicine, the importance of healthcare information technology in providing quality care, and the promising future of Emory Hospital Medicine and the field of hospital medicine.


Michael Segal, MD, PhD

Latest:

Medical Decision Support Software: Have Our Hopes and Fears Come True?

Medical decision support software is the term used for computer programs and associated databases that help make diagnoses and advise on treatment.




Brian Olshansky, MD: From the Division of Cardiology, University of Iowa Hospitals

Latest:

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

The effects of recurrent tachycardia after resolution of cardiomyopathy have not been thoroughly assessed. We evaluated and followed 24 patients with tachycardia-induced cardiomyopathy for more than 12 years. Our observations showed that patients with tachycardia-induced cardiomyopathy may be at long-term risk for sudden death. Surreptitious cardiomyopathy due to occult ultrastructural changes may persist. It has yet to be determined whether rapid and aggressive rate control would prevent structural damage to risk of sudden cardiac death.


Scott R. Yoder, MD

Latest:

Direct renin inhibition in the elderly

Hypertension may well be the most important public health issue facing society today.




Linda Englander, SPHR

Latest:

Why We’re Not Reaching Women With Metastatic Breast Cancer and How We Can Change That

Breast Cancer Network of Strength is always looking for different ways to meet the needs of women with breast cancer.



Donald M. Lloyd-Jones, MD, ScM

Latest:

Lifetime risk of atrial fibrillation

Using data from 8,725 participants in the Framingham Heart Study who were followed for 176,166 person-years, we estimate that the lifetime risk of developing atrial fibrillation (AF) is 1 in 4 for men and women aged 40 years and older. Even when there is no antecedent congestive heart failure or myocardial infarction, the lifetime risk of AF is high (1 in 6). This significant lifetime risk highlights the major public health problem resulting from AF and the need for further study into causes, prevention, and treatment.


Don S. Dizon

Latest:

So Close and Yet so Far...

The holy grail in women's oncology is early detection. This is most painfully true for ovarian cancer, where symptoms often suggest that the disease has already advanced.


Shakaib U. Rehman, MD

Latest:

Ethnic differences in blood pressure control in men

We compared blood pressure control among white and African American hypertensive men in Veterans Affairs (VA) and non-VA sites, and found that the dis parity between the two ethnic groups was 40% less at VA sites. Better access to care and medications for African Americans at the VA sites may explain the difference.


Harvard Medical School, Boston, Massachusetts.

Latest:

Cholesterol-lowering therapies and C-reactive protein

Low-density lipoprotein (LDL) cholesterol-lowering therapy decreases C-reactive protein (CRP) levels, but the importance of LDL cholesterol-independent effects is uncertain because of the variability in measuring LDL cholesterol and CRP levels in any individual patient. In this study, this variability was reduced by comparing average changes in LDL cholesterol and CRP levels after treatment with lipid-lowering therapy across different studies.


Christina T. Loguidice

Latest:

Study identifies factors that help determine risk of bone metastases in breast cancer patients

A study published in the July 2010 issue of BMC Cancer found that tumor grade (T), nodal grade (pN), and histopathology were useful factors in classifying breast cancer patients who underwent surgery as having high, medium, or low risk of developing bone metastases.





Jackie Syrop

Latest:

Musculoskeletal Pain, Limited Physical Function in Obese Teens

A new study of obese adolescents highlighted the link between obesity and chronic musculoskeletal (MSK) pain and limitations on physical function and quality of life (QOL).



© 2024 MJH Life Sciences

All rights reserved.